Evaluation of the antidepressant, anxiolytic and memory-improving efficacy of aripiprazole and fluoxetine in ethanol-treated rats

References

• Beatty WW, Katzung VM, Moreland VJ, Noxon SJ. (1995). Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug Alcohol Depend 37:247–253
   PubMed Web of Science ®Google Scholar
• Berk M, Dodd S, Kauer-Sant'anna M, Hascoët M. (2007). Dopamine disregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl 434:41–49
   PubMedGoogle Scholar
• Bourin M, Chenu F, Prica C, et al. (2009). Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice. Psychopharmacology 206:97–107
   PubMed Web of Science ®Google Scholar
• Burda K, Czubak A, Kus K, et al. (2011). Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats. Pharmacol Rep 63:898–907
   PubMed Web of Science ®Google Scholar
• Burris KD, Molski TF, Xu C, et al. (2002). Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302:381–389
   PubMed Web of Science ®Google Scholar
• Conway KP, Compton W, Stinson FS, Grant BF. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug of use disorders: results from the National Epidemiologic Survey on Alcohol and Releated Conditions. J Clin Psychiatry 67:247–257
   PubMed Web of Science ®Google Scholar
• Crawley JN. (1981). Neuropharmacologic specificity of simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15:695–699
   PubMed Web of Science ®Google Scholar
• Di Chiara G, Imperato A. (1985). Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur J Pharmacol 115:131–132
   PubMed Web of Science ®Google Scholar
• Egashira N, Okuno R, Matsushita M, et al. (2008). Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms. Eur J Pharmacol 592:103–108
   PubMed Web of Science ®Google Scholar
• Enomoto T, Ishibashi T, Tokuda K, et al. (2008). Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats. Behav Brain Res 186:197–207
   PubMed Web of Science ®Google Scholar
• Gessa GL, Muntoni F, Collu M, et al. (1985). Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 348:201–203
   PubMed Web of Science ®Google Scholar
• Ilgen M, Moos R. (2005). Deterioration following alcohol use disorder treatment in Project MATCH. J Stud Alcohol Drugs 66:517–525
   PubMed Web of Science ®Google Scholar
• Ishiyama T, Tokuda K, Ishibashi T, et al. (2007). Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test. Eur J Pharmacol 572:160–170
   PubMed Web of Science ®Google Scholar
• Jordan S, Koprivica V, Chen R, et al. (2002). The antipsychotic aripiprazole is a potent, partial agonist at human 5-HT1A receptor. Eur J Pharmacol 441:137–140
   PubMed Web of Science ®Google Scholar
• Kamei J, Miyata S, Sunohara T, et al. (2008). Potentiation of the antidepressant-like effect of fluoxetine by aripiprazole in the mouse tail suspension test. J Pharmacol Sci 108:381–384
   PubMed Web of Science ®Google Scholar
• Kessler RC, Crum RM, Warner LA, et al. (1997). Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 54:313–321
   PubMed Web of Science ®Google Scholar
• Lal H, Prather PL, Rezazadeh SM. (1993). Potential role of 5HT1C and/or 5HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal. Alcohol Clin Exp Res 17:411–417
   PubMed Web of Science ®Google Scholar
• Li Z, Ichikawa J, Dai J, Meltzer HY. (2004). Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur J Pharmacol 493:75–83
   PubMed Web of Science ®Google Scholar
• Maj J, Rogoz Z. (1999). Synergistic effect of pramipexole and sertraline in the forced swimming test. Pol J Pharmacol 51:471–475
   PubMedGoogle Scholar
• Marder SR, McQuade RD, Stock E, et al. (2003). Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res 61:123–136
   PubMed Web of Science ®Google Scholar
• Mikołajczak P, Okulicz-Kozaryn I, Kaminska E, et al. (2003). Lack of ifenprodil anxiolytic activity after its multiple treatment in chronically ethanol-treated rats. Alcohol Alcohol 38:310–315
   PubMed Web of Science ®Google Scholar
• Morley JE, Thomas DR, Wilson MM. (2006). Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83:735–743
   PubMed Web of Science ®Google Scholar
• Morris R. (1984). Development of a water-maze procedure for studying spatial learning in a rat. J Neurosci Methods 11:47–60
   PubMed Web of Science ®Google Scholar
• Nordmann R. (1994). Alcohol and antioxidant systems. Alcohol 29:513–522
   Web of Science ®Google Scholar
• Nowakowska E, Chodera A, Kus K. (1996). Anxiolytic and memory improving activity of fluoxetine. Pol J Pharmacol 48:255–260
   PubMedGoogle Scholar
• Nowakowska E, Kus K, Chodera A, Rybakowski J. (2000). Behavioural effects of fluoxetine and tianeptine, two antidepressants with opposite action mechanisms, in rats. Arzneimittelforschung 50:5–10
   PubMed Web of Science ®Google Scholar
• Okulicz-Kozaryn I, Mikołajczak P, Kamińska E, et al. (2004). Effect of naltrexone administration on short-term memory in chronically ethanol-treated outbred rats. Alcohol Alcohol 39:14–19
   PubMed Web of Science ®Google Scholar
• Pae CU, Serretti A, Patkar AA. (2008). Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence. CNS Drugs 22:367–388
   PubMed Web of Science ®Google Scholar
• Porsolt RD, Anton G, Blavet N, Jalfre M. (1978). Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391
   PubMed Web of Science ®Google Scholar
• Potkin SG, Saha AR, Kujawa MJ, et al. (2003). Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 60:681–690
   PubMed Web of Science ®Google Scholar
• Preskorn SH. (2003). Relating clinical trials to psychiatric practice: part I: the case of a 13-year old on aripiprazole and fluoxetine. J Psychiatr Pract 9:307–313
   PubMedGoogle Scholar
• Ratti MT, Giardini A, Soragna D. (2002). Chronic alcoholism and the frontal lobe: which executive functions are impaired? Acta Neurol Scand 105:276–281
   PubMed Web of Science ®Google Scholar
• Renard CE, Dailly E, David DJ, et al. (2003). Neurochemical changes following the mouse forced swimming test but not the tail suspension test. Int J Neuropsychopharmacol 17:449–455
   Google Scholar
• Renard CE, Dailly E, Nic Dhonnchadha BA, et al. (2004). Is dopamine a limiting factor of the antidepressant-like effect in the mouse forced swimming test? Prog Neuropsychopharmacol Biol Psychiatry 28:1255–1259
   PubMed Web of Science ®Google Scholar
• Renard CE, Fiocco AJ, Clenet F, et al. (2001). Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test? Psychopharmacology 159:42–50
   PubMed Web of Science ®Google Scholar
• Sachs GS, Sanchez R, Marcus RN, et al. (2006). Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacol 20:536–546
   PubMed Web of Science ®Google Scholar
• Semba J, Watanabe A, Kito S, Toru M. (1995). Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brain. Neuropharmacology 34:785–791
   PubMed Web of Science ®Google Scholar
• Silva MTA, Alves CRR, Santarem EMM. (1999). Anxiogenic-like effect of acute and chronic fluoxetine on rats tested on the elevated plus-maze. Brazil J Med Biol Res 32:333–339
   PubMed Web of Science ®Google Scholar
• Sullivan EV, Deshmukh A, De Rosa E, et al. (2005). Striatal and forebrain nuclei volumes: contribution to motor function and working memory deficits in alcoholism. Biol Psychiatry 57:768–776
   PubMed Web of Science ®Google Scholar
• Vieta E, Bourin M, Sanchez R, et al.; Aripoprazole Study Group. (2005). Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomized, comparative 12-week trial. Br J Psychiatry 187:235–242
   PubMed Web of Science ®Google Scholar
• Weiss F, Porrino LJ. (2002). Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci 22:3332–3337
   PubMed Web of Science ®Google Scholar
• Yatham LN, Goldstein JM, Vieta E, et al. (2005). Atypical antipsychotic in bipolar depression: potential mechanism of action. J Clin Psychiatry 66:40–48
   PubMed Web of Science ®Google Scholar
• Zhang Y, Raap DK, Garcia F, et al. (2000). Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats. Brain Res 855:58–66
   PubMed Web of Science ®Google Scholar